-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 17, Rundu Pharmaceutical announced that the company has recently received the "Drug Registration Approval" for itopride hydrochloride tablets issued by the State Drug Administration
Itopride hydrochloride tablets are suitable for dyspepsia symptoms caused by slowed gastrointestinal motility (such as functional dyspepsia, chronic gastritis, etc.
On July 31, 2020, Rundu Pharmaceutical submitted an application for drug registration of itopride hydrochloride tablets to the Drug Evaluation Center of the State Drug Administration, and it was accepted
According to the relevant national policies, itopride hydrochloride tablets approved for production according to Category 4 chemicals can be regarded as passing the consistency evaluation of generic drugs